Literature DB >> 25459397

A comparison of function after limb salvage with non-invasive expandable or modular prostheses in children.

Kirsten K Ness, Michael D Neel, Sue C Kaste, Catherine A Billups, Victoria G Marchese, Bhaskar N Rao, Najat C Daw.   

Abstract

BACKGROUND: Modular and non-invasive expandable prostheses have been developed to provide a functional knee joint that allows future expansion as growth occurs in the contralateral extremity in children with bone sarcomas that require removal of the growth plate. This study aimed to evaluate the functional outcomes of paediatric patients who received either a non-invasive expandable or modular prosthesis for bone sarcomas arising around the knee.
METHODS: We evaluated clinician-reported, patient-reported and measured function in 42 paediatric patients at least one year (median age at assessment 19.1 years) after limb salvage surgery, and compared patients who received modular system prostheses (N = 29, median age 15.5), who did not require lengthening procedures to those who received non-invasive expandable prostheses (N = 13, median age 11.1) requiring lengthening procedures (median 5).
RESULTS: The number of revisions and time to first revision did not differ between the two groups. There were no differences between the two groups in total scores on the Enneking Musculoskeletal Tumor Society Scale, the Toronto Extremity Salvage Scale, and the Functional Mobility Assessment. Children with non-invasive expandable prostheses climbed stairs (11.93 ± 4.83 versus 16.73 ± 7.24 s, p = 0.02) in less time than those with modular prostheses.
CONCLUSION: Our results suggest that the non-invasive expandable prosthesis produces similar functional results to the more traditional modular prosthesis.

Entities:  

Mesh:

Year:  2014        PMID: 25459397      PMCID: PMC4303497          DOI: 10.1016/j.ejca.2014.10.005

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  18 in total

Review 1.  Common musculoskeletal tumors of childhood and adolescence.

Authors:  C A Arndt; W M Crist
Journal:  N Engl J Med       Date:  1999-07-29       Impact factor: 91.245

2.  Mobile knee reconstructions after resection of malignant tumors of the distal femur.

Authors:  J S Kneisl; H A Finn; M A Simon
Journal:  Orthop Clin North Am       Date:  1991-01       Impact factor: 2.472

3.  The Van Nes tibial rotationplasty. A functionally viable reconstructive procedure in children who have a tumor of the distal end of the femur.

Authors:  F P Cammisa; D B Glasser; J C Otis; M A Kroll; J M Lane; J H Healey
Journal:  J Bone Joint Surg Am       Date:  1990-12       Impact factor: 5.284

Review 4.  Modular endoprostheses for children with malignant bone tumors.

Authors:  M D Neel; G D Letson
Journal:  Cancer Control       Date:  2001 Jul-Aug       Impact factor: 3.302

5.  Development of a measure of physical function for patients with bone and soft tissue sarcoma.

Authors:  A M Davis; J G Wright; J I Williams; C Bombardier; A Griffin; R S Bell
Journal:  Qual Life Res       Date:  1996-10       Impact factor: 4.147

Review 6.  Limb-salvage surgery in the treatment of osteosarcoma in skeletally immature individuals.

Authors:  H A Finn; M A Simon
Journal:  Clin Orthop Relat Res       Date:  1991-01       Impact factor: 4.176

7.  A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.

Authors:  W F Enneking; W Dunham; M C Gebhardt; M Malawar; D J Pritchard
Journal:  Clin Orthop Relat Res       Date:  1993-01       Impact factor: 4.176

8.  Early multicenter experience with a noninvasive expandable prosthesis.

Authors:  Michael D Neel; Ross M Wilkins; Bhaskar N Rao; Cynthia M Kelly
Journal:  Clin Orthop Relat Res       Date:  2003-10       Impact factor: 4.176

Review 9.  The management of malignant bone tumors in children and adolescents.

Authors:  M Mercuri; R Capanna; M Manfrini; G Bacci; P Picci; P Ruggieri; A Ferruzzi; A Ferraro; D Donati; R Biagini
Journal:  Clin Orthop Relat Res       Date:  1991-03       Impact factor: 4.176

10.  Function and quality-of-life of survivors of pelvic and lower extremity osteosarcoma and Ewing's sarcoma: the Childhood Cancer Survivor Study.

Authors:  R Nagarajan; D R Clohisy; J P Neglia; Y Yasui; P A Mitby; C Sklar; J Z Finklestein; M Greenberg; G H Reaman; L Zeltzer; L L Robison
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640

View more
  5 in total

1.  Are Complications Associated With the Repiphysis(®) Expandable Distal Femoral Prosthesis Acceptable for Its Continued Use?

Authors:  Eric L Staals; Marco Colangeli; Nikolin Ali; José M Casanova; Davide M Donati; Marco Manfrini
Journal:  Clin Orthop Relat Res       Date:  2015-05-21       Impact factor: 4.176

2.  What Are the Complications of Allograft Reconstructions for Sarcoma Resection in Children Younger Than 10 Years at Long-term Followup?

Authors:  Luis A Aponte-Tinao; Jose I Albergo; Miguel A Ayerza; D Luis Muscolo; Federico Milano Ing; German L Farfalli
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

3.  When Do Orthopaedic Oncologists Consider the Implantation of Expandable Prostheses in Bone Sarcoma Patients?

Authors:  Magdalena M Gilg; Christine Wibmer; Marko Bergovec; Robert J Grimer; Andreas Leithner
Journal:  Sarcoma       Date:  2018-02-25

4.  Physical and functional performance assessment in pediatric oncology: a systematic review.

Authors:  Regine Söntgerath; Julia Däggelmann; Sabine V Kesting; Corina S Rueegg; Torge-Christian Wittke; Simon Reich; Katharina G Eckert; Sandra Stoessel; Carolina Chamorro-Viña; Joachim Wiskemann; Peter Wright; Anna Senn-Malashonak; Vanessa Oschwald; Anne-Marie Till; Miriam Götte
Journal:  Pediatr Res       Date:  2021-04-15       Impact factor: 3.953

5.  Alterations in Muscle Architecture: A Review of the Relevance to Individuals After Limb Salvage Surgery for Bone Sarcoma.

Authors:  Christa M Nelson; Victoria Marchese; Kelly Rock; Robert M Henshaw; Odessa Addison
Journal:  Front Pediatr       Date:  2020-06-16       Impact factor: 3.569

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.